/

Società

Ba

Non verificato

Baszucki Group

Di cosa scriviamo

FitnessIndustriaMedicina - VariePsichiatriaSalute

13 comunicati stampa

Guarda tutti i comunicati

21/10/2026

Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital

Fonte

Emittente

1.00

0

14/10/2026

New Study Brings Ketogenic Therapy for Bipolar Disorder Directly to Rural Alabama Homes

Fonte

Emittente

1.00

0

08/07/2026

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders

Fonte

Emittente

1.00

0

03/06/2026

New Evidence Offers Hope for Ketogenic Therapy in Treatment of Anorexia Nervosa

Fonte

Emittente

1.00

0

21/05/2026

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis

Fonte

Emittente

1.00

0

10/12/2025

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

Fonte

Emittente

1.00

0

04/12/2025

University of Maryland Launches Innovative Clinician Training Program in Ketogenic Metabolic Therapy for Mental Health

Fonte

Emittente

1.00

0

21/10/2025

Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation

Fonte

Emittente

1.00

0

10/09/2025

Multimedialità

Sanità

Salute

Psichiatria

Università

Fitness

Scuola/Istruzione

Medicina - Varie

Analisi di mercato

Industria

New Study of College Students with Depression Adds to Growing Evidence for Ketogenic Therapy as a Mental Health Treatment

Fonte

Emittente

1.00

0

12/03/2025

Baszucki Group Announces Two Research Initiatives for Youth with Bipolar

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0